321 filings
Page 4 of 17
6-K
mxry0 g0hj
2 Sep 21
BELLUS Health to Present at the H.C. Wainwright Global Investment Conference
7:00am
6-K
yz9hu55 zanc
23 Aug 21
BELLUS Health to Report Additional RELIEF Data in an Oral Presentation at the European Respiratory Society International Congress 2021
7:00am
6-K
ez5q9trs
11 Aug 21
Condensed Consolidated Interim Financial Statements of
4:43pm
6-K
0sn7 0q67qw8lfm37
11 Aug 21
BELLUS Health Reports Second Quarter 2021 Financial Results and Business Highlights
4:31pm
6-K
oh56mh ux
25 May 21
BELLUS Health to Participate in the Jefferies Virtual Healthcare Conference
7:00am
6-K
2wc7ollt3b
12 May 21
BELLUS Health to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
7:00am
6-K
p09fkz1ygj1gf3k9f
10 May 21
Condensed Consolidated Interim Financial Statements of
4:48pm
6-K
3n40r0xgjwh9y6kmmi9y
10 May 21
BELLUS Health Reports First Quarter 2021 Financial Results and Business Highlights
4:30pm
6-K
hhlv3n2m0s3degb hfb
10 May 21
BELLUS Health to Present at the American Thoracic Society 2021 International Conference
7:03am
6-K
57zpldh4ik46c8rdss
13 Apr 21
BELLUS Health to Present at the Bloom Burton & Co. Healthcare Investor Conference
7:00am
6-K
w1kddw1sl9uc
9 Apr 21
Notice of Annual Meeting of Shareholders
12:00am
6-K
e9ih65
8 Apr 21
Bellus HEALTH 2020 ANNUAL REPORT
10:16am
6-K
x7tw76o3h4pu09ia06
24 Mar 21
BELLUS Health Appoints William Mezzanotte, MD, MPH to its Board of Directors
7:00am
6-K
sbzz8 f81
5 Mar 21
Report of Foreign Private Issuer for the Month of March 2021
11:43am
6-K
on6y0z43er3jdl13z5t
25 Feb 21
BELLUS Health Reports Year 2020 Financial Results and Business Highlights
4:02pm
6-K
61sce ugt381
22 Feb 21
BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences
7:00am
6-K
8tn 4zp6qsfs80d0mced
14 Jan 21
Bellus Health Inc. 6-K
7:00am
6-K
c4fgp8nqdceii5
23 Dec 20
Open Market Sale Agreementsm
5:06pm
6-K
fp45wn y7snr8
14 Dec 20
Bellus Health Inc. Form 6-K
7:01am
6-K
ubpon9s6 z8i2
8 Dec 20
BELLUS Health Announces First Patient Dosed in its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am